• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 27 of 100
Image of a predicted protein structure rom the malaria parasite
HealthIn giant leap for biology, DeepMind’s A.I. reveals secret building blocks of human life
By Jeremy KahnJuly 22, 2021
A picture of a protein shape.
TechDeepMind unveils how it solved a 50-year-old scientific challenge that could speed drug discovery
By Jeremy KahnJuly 15, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
NewslettersThe never ending Biogen Alzheimer’s drug saga delivers yet another twist
By Sy MukherjeeJuly 8, 2021
Biogen aduhelm aducanumab Alzheimer's doctor disapproval
HealthBiogen makes a drastic move, as doctors refuse to prescribe its controversial Alzheimer’s drug
By Sy MukherjeeJuly 8, 2021
CommentaryCures for many rare diseases might already exist. Why aren’t we using them?
By Annette BakkerJuly 5, 2021
HealthGlaxo reaches $2.2 billion deal with Alector to develop drug targeting Alzheimer’s, Parkinson’s
By Suzi Ring and BloombergJuly 2, 2021
HealthStates step up push to regulate pharmacy drug brokers
By Katheryn Houghton and Kaiser Health NewsJune 30, 2021
EyebrowWant cheaper insulin? Try Walmart
By Marco Quiroz-GutierrezJune 29, 2021
Intellia CRISPR gene editing stock science
HealthWe can now edit genes inside the body. That sent this biotech’s stock soaring
By Sy MukherjeeJune 28, 2021
COVID Delta Delta plus variants
NewslettersThe delta between the Delta variants
By Sy MukherjeeJune 24, 2021
Janet Woodcock, acting commissioner of the U.S. Food and Drug Administration (FDA), listens during a Senate Appropriations Subcommittee hearing in Washington, D.C., U.S., on Thursday, June 10, 2021. The hearing is titled "Fiscal Year 2022 Budget Request for the FDA." Photographer: Al Drago/Bloomberg via Getty Images
HealthPressure mounts on Biden to nominate permanent FDA head as dissatisfaction with agency grows
By Sy MukherjeeJune 22, 2021
A woman in an Allcyte lab coat looking at images of cancer cells on a screen.
TechBritish A.I. drug discovery startup Exscientia buys Austrian cancer cell screening company
By Jeremy KahnJune 15, 2021
The exterior of the headquarters of biotechnology company Biogen in Cambridge, MA is pictured on March 21, 2019.
HealthBiogen won its controversial Alzheimer’s drug approval. Which drugmakers will see the next big win?
By Sy MukherjeeJune 9, 2021
HealthCassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
By Cristin Flanagan and BloombergJune 8, 2021
HealthAmazon begins offering six-month prescriptions for as low as $6
By Chris MorrisJune 8, 2021
1...
  • 25
  • 26
  • 27
  • 28
  • 29
...100
Most Popular
Personal Finance
The national debt isn't $39 trillion. One economist says it's actually $100 trillionAn image of a popular article
By Nick LichtenbergMarch 13, 2026
Success
When Jamie Dimon was fired from Citigroup, his daughters asked: 'Will we be homeless? Can I still go to college? Can I have your phone?'An image of a popular article
By Eleanor PringleMarch 13, 2026
Economy
Trump's immigration crackdown is backfiring by hurting the U.S.-born workers it was meant to help, data showsAn image of a popular article
By Sasha RogelbergMarch 10, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
Fortune Secondary Logo
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.